Post hoc analysis of the CAMERA2 trial in MRSA bacteraemia: early, late or throughout β-lactam use was associated with faster clearance vs none (adjusted HR 1.59-1.85); AKI odds rose with late (OR 6.01) and throughout (OR 7.93) use but not early use (OR 1.24).
Secondary analysis
Petersiel et al. Association between β-lactam exposure and clearance of bacteraemia and acute kidney injury in patients with methicillin-resistant Staphylococcus aureus bloodstream infections-a post hoc analysis of the CAMERA2 trial